Observation of the Result After Chondron (Autologous Chondrocytes) Treatment
|Articular Cartilage Defects of Knee||Procedure: Autologous Chondrocyte Implantation|
|Study Design:||Observational Model: Case-Only
Time Perspective: Retrospective
|Official Title:||An Investigator-sponsored Trial for Observation of the Result After Chondron (Autologous Chondrocytes) Treatment|
- Change of KSS(Knee Society Score)-A,B [ Time Frame: pre-operation, post -operation 4month, post-operation 12month, over post-operation 24month. ]
- Additional treatment related to autologous chondrocyte implantation [ Time Frame: post -operation 4month, post-operation 12month, over post-operation 24month. ]
- Satisfaction of patients [ Time Frame: post -operation 4month, post-operation 12month, over post-operation 24month. ]
|Study Start Date:||December 2008|
|Study Completion Date:||November 2009|
|Primary Completion Date:||August 2009 (Final data collection date for primary outcome measure)|
This clinical trial was a follow-up study involving 127 patients from 10 hospitals, for whom autologous chondrocyte transplantation was already performed. All the subjects were investigated as a single group
Procedure: Autologous Chondrocyte Implantation
Suspend the cells in the vial sufficiently, and implant them in the defective part, making sure that sufficient amounts are injected.
Other Name: Chondron(671500010 [ A74600011 ])
Many treatment cases proved that autologous chondrocyte transplantation is a useful treatment method for patients with damaged articular cartilage.
This investigator-sponsored trial attempts to evaluate the effectiveness of Chondron(autologous chondrocyte) transplantation by tracking subjects who had the Chondron implantation to observe effectiveness.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01056900
|Korea, Republic of|
|Sungdong-ku, Seoul, Korea, Republic of, 133-831|
|Principal Investigator:||Nam Yong Choi||St. Paul Hospital of Catholic Medical College|